WPRIM Management System> DCMS> China Oncology> 1998> 0> 01

Volume: 0 Issue: 01

2. Signifance of serum CA153 in the differential diagnosis between benign and malignant lung diseases Page:—
3. Diagnostic utility of detection of CEA mRNA, CEA and CA19-9 in benign and malignant hydrothorax Page:—
4. Ki-67 antigen's expression in benign and malignant neoplasms of colorectum and its clinical significance Page:—
5. Therapy of murine gastric cancer by 5-FC/CD suicide gene system combined with HSP-PC tumor vaccine Page:—
6. Expression of Fas/FasL in lung cancer and its significance Page:—
7. Relation between apoptosis and proliferation or genes expression after chemotherapy in ovarian eithelial carcinoma Page:—
8. Postoperative irradiation after radical surgery of esophageal carcinoma Page:—
9. Ifosfamide and other 3 drugs chemotherapy for 24 cases with recurrent intermediate—high grade non-Hodgkin's lymphoma Page:—
10. Expression of CD44V6 and p53 gene mutation in human ovarian carcinoma Page:—
11. Advances in the relationship betreen tumor and venous thromboembolism Page:—
12. Advances in research on the expression of matrix metalloproteinases in gastrointestinal cancer and their inhibitors in treatment Page:—
13. Advancement of breast cancer and angiogenesis Page:—
14. Advances in research on relation of ubiquitin-proteasome pathway to malignancy Page:—
15. Surgical treatment and perioperative period management for 182 elderly patients with colonic carcinoma Page:—
16. Drainage and treatment of 12 cases with lung cancer hydropericardium by puncturing the pericardum and inserting central venous catheter into pericardial cavity Page:—
17. Clinical application of transdermal fentanyl for 30 patients with moderate or severe cancer pain Page:—
18. Continuous infusion of fluorouracil lasting 240 hours in 35 cases with gastric cancer Page:—
19. Effect of chemotherapy on plasma endothelin level in gastric carcinoma patients and its significance Page:—
20. Three different regimens of CF/5-FU,DDP in treatment of patients with advanced gastrointestinal adenocarcinoma Page:—
21. Carboplatin and cisplatin combined with etopside in patients with advanced non-small-cell lung cancer Page:—
22. Idarubicin combined chemotherapy regimen for 22 cases with refractory or relapsed multiple myeloma Page:—
23. Radiotherapy combined with the chemotherapy for 64 patients with advanced esophageal cancer Page:—
24. Expression and clinical significance of p27 in esophageal carcinoma Page:—
25. Correlation between the expression of gene protein of c-fos, bcl-2 and gastric cancer Page:—
26. Expression of P53 and its relationship with HBV infection in hepatocellular carcinomas and chronic liver diseases Page:—
27. Advances research in third generation aromatase inhibitors in adjuvant therapy of postmenopausal women with early breast cancer Page:—
28. CGH and advances in the study of colorectal carcinoma Page:—
29. Initial study on gemcitabine with lipiodol emulsion in the treatment of advance dliver cancer Page:—
30. Effects of arsenic trioxide on different types of human ovarian cancer cell lines in vitro Page:—
31. Diagnosis and treatment of Hashimoto’s disease complicated with thyroid cancer Page:—
32. Comparison of the two methods for screening osteosarcoma cell sublines with different metastatic potential in vitro Page:—
33. Glucocorticoid up-regulated T?R-Ⅱ in ovarian cancer HO-8910 cells Page:—
34. Advances in dendritic cells vaccines Page:—
35. The connective tissue growth factor and angiogenesis in breast carcinoma Page:—
36. Morphine controlled-release tablets plus diclofenac sodium in the treatment of pain of bone metastatic carcinoma Page:—
37. Value of radiotherapy following breast-conserving surgery in early stage breast cancer Page:—
38. The diagnosis and treatment of rectal carcinoid: a report of 43 cases Page:—
39. Clinical study on thalidomide alone or combined with dexamethasone in the treatment of relapsed and refractory multiple myeloma Page:—
40. Surgery combined with intraoperative radiotherapy compared with surgery alone for rectal carcinoma Page:—
41. Phase Ⅱ clinical study of gemcitablineplus etoposite in treatment of advanced non-small-cell carcinoma Page:—
42. Clinical study of TEP regimen in the treatment of small cell lung cancer Page:—
43. Cryotherapy combining with ethanol injection therapy in the treatment of irresec table hepatic cancer Page:—
44. A phase Ⅰ/Ⅱ clinical trial of three dimensional conformal radiation therapy combined with transcatheter arterial chemoembolization for liver cancer Page:—
45. Prognostic predictors for breast cancer patients with brain metastasis after rad iotherapy Page:—
46. The value of predicting the axillary lymph node(ALN) metastases status by sentinel lymph node biopsy(SLNB) with methylene blue subcantaneous injection in the breast cancer Page:—
47. Clinical study of t-PA and u-PA expression in patients with gastric or intestinal cancer Page:—
48. The significance of abdominal residue after primary cytoreductive surgery forst age Ⅲ ovarian cancer Page:—
49. Expression of Epstein-Barr virus gene BARF1 in the nasopharyngeal carcinoma and its significance Page:—
50. Microsatellite analysis of BAT-26 and BAT-25 in nodal non-Hodgkin′s lymphomas Page:—
51. Expression of survivin gene in the dysplasia of gastric mucous epithelium and the gastric carcinoma and its significance Page:—
52. Expression of survivin in gastric carcinoma and analysis of its correlation with COX-2 Page:—
53. Phase Ⅱ clinical study of intratumoral H101,an E1B deleted adenovirus,in patients with cancer Page:—
54. BSO up-regulating cisplatin sensitivity of a MRP-overexpression lung cell line SPC-A-1 by changing the activity of GSH detoxification system Page:—
55. The inhibition of the malignant phenotype of human hepatic carcinoma cell line by antisense ?-catenin cDNA Page:—
56. The effect of HPA gene transfection on the proliferation、adhesion、invasion of human ovarian cancer cell line SKOV3 Page:—
62. The clinical efficacy observation of VAD regimen in the treatment of newly diagn osed multiple myeloma Page:—
63. Analysis of clinical characteristics of premenopausal and postmenopausal female patients with breast cancer Page:—
64. Comparison between old and new clinical staging of primany liver cancer Page:—
65. Study of approaches in surgery of esophageal cancer Page:—
66. Gemcitabine and cisplatin combination chemotherapy in refractory metastatic breast cancer Page:—
67. Study of mechanism of radiation sensitizing effect of topotecan on nasopharyngeal carcinoma Page:—
68. Three dimensional conformal radiotherapy for metastasis of retroperitoneal lymph node Page:—
69. The relationship between postoperative survival rate and clinical stage of gallb ladder carcinoma Page:—
70. Expression and clinical studies on FLK-1,LRP and MDR1 in lung cancer patients Page:—
71. Coxmultivariate regression analysis of prognostic factors for extrahepatic chol angiocarcinoma Page:—
72. Histologic detection of non-sentinel lymph node of early breast cancer patients with positive sentinel lymph node and its clinical significance Page:—
73. Targeted therapy of metastatic renal cell carcinoma Page:—
74. Targeted therapy for colorectal cancer Page:—
75. Colorectal cancer screening Page:—
76. Microtubule-destabilizing protein stathmin—a new target for gene therapy of cancer Page:—
77. Targeted therapies in the treatment of gastric cancer Page:—
78. Application of proteomic techniques in searching lung cancer biomarkers Page:—
79. Clinical study of navelbine plus paclitaxel for patients with advanced breast cancer Page:—
80. The expression of breast cancer resistance protein(BCRP) in primary breast carcinoma and its clinical impact Page:—
81. The clinical benefit of CPT-11 combined with 5-FU/CF for patients with locally advanced or metastatic colorectal cancer Page:—
82. Study of cell growth inhibition and apoptosis induced by oxaliplatin in human poor differentiation nasopharyngeal carcinoma cell line-CNE2 Page:—
83. Surgical management and prognostic analysis on recurrent colorectal carcinomas Page:—
84. Animal study on the feasibility of regional gastroduodenal artery or splenic artery ligation followed by regional intraarterial perfusion of pancreas with 5-FU Page:—
85. PTEN inhibited the invasion of glioma cells with a common mutant epidermal growth factor receptor expression by dephosphorylating FAK Page:—
86. Differential metastasis-related gene analysis of prostate cancer cells isolated from primary tumor and spontaneous metastases in nude mice with orthotopic injection of PC-3M cells by cDNA microarray Page:—
87. The research of different MRI-CT image registration for the stability of radiotherapeutic target delineation on gliomas after surgery Page:—
88. Study on expression and clinical significance of uPAR and VEGF-C in ovarian cancer Page:—
89. The study of lung adenocarcinoma serum biomarkers selected by surface-enhanced laser desorption ionization spectrometry Page:—
90. Development of targeted therapy on gastroeternaral tumor Page:—
91. The evidence-based adjuvant chemotherapy for colon cancer Page:—
92. Cytochrome P450 and tumor Page:—
93. Application of XRCC1 gene in cancer research Page:—
94. Memory T cells in tumor immunity Page:—
95. Progress in effects of the HGF/SF-c-Met on progression of tumors and inhibitors of its pathway Page:—
96. Relationship of MGB-2 expression and chemotherapy response and prognosis in human ovarian carcinoma Page:—
97. Cloning of hTERT promoter and its specific transcriptional activity in MCF7 breast cancer cell Page:—
98. Apoptotic effect of RIZ1 expression on human myeloid leukemic cell lines Page:—
99. siRNAs silence expression of mdr1 gene and its role in reversing drug-resistance in K562/ADM cells Page:—
100. Targeted therapy of lung cancer-data from Asia Page:—
101. Advances in the targeted therapy of cancer:multi-targeted Raf kinase inhibitor Page:—
102. Advances in the experimental and clinical research of pemetrexed Page:—
103. Modified radical mastectomy-stage Ⅰ expansion of latissimus dorsi muscle flap breast reconstruction Page:—
104. Weekly and three-weeks' docetaxel,cisplatin and 5-FU treatment in advanced gastric carcinoma Page:—
105. A study on regulation of DNA mismatch repair genes MLH1 and MSH2 in human SCLC cell line H446 under hypoxic condition Page:—
106. Prognostic factors of epithelial ovarian carcinoma in patients with age under 40 Page:—
107. Palliative resection of advanced gastric cancer Page:—
108. Establishment of 451 bp fragment that functionally related to transportation in hepatocellular carcinoma supressor gene-1(HCCS1) Page:—
109. Treatment of advanced gastric cancer with the regimen of etoposide,folinic acid and fluorouracil Page:—
110. Comparison and analysis of the operation approach of esophageal carcinoma Page:—
111. Expression and clinical significance of nm23-H_1 and nm23-H_2 in human breast cancer Page:—
112. Cloning of 5'flank upstream regulation region of LCRG1 and the measurement of promoter activity Page:—
113. Quantitative parameters on nuclear DNA of ovarian mucinous cystadenomatous in differential diagnosis Page:—
114. Effects of EGCG on regulating NF-?B/p65 induced by TNF-? and on inducing apoptosis Page:—
115. Effect of elemene emulsion on gene expression of telomerase catalytic subunit in HeLa cell Page:—
116. Clinical analysis of combined esophageal stent inserting with three-dimensional conformal radiotherapy and concurrent chemotherapy on esophageal carcinoma Page:—
117. Effects of antidiabetic drug metformin on human lung adenocarcinoma cell A549 proliferation and apoptosis in vitro Page:—
118. Expression of Survivin,Caspase-3 and Bcl-2 in lung carcinoma Page:—
119. Correlation between CXCR4,VEGF and the blood metastasis of osteosarcoma Page:—
120. Expression of c-kit receptor in acute leukemia and its clinical significance Page:—
121. Advances in the research on relationship between p27Kip1 and digestive tumors Page:—
122. Advances of the research in gene therapy for prostate cancer Page:—
123. The activity of gemcitabine in advanced non-small-cell lung cancer Page:—
124. Factors relating to cross infection in hospital of cancer patients Page:—
125. Epidemiological study of the influence of drinking green tea on gastric cancer and chronic gastritis incidence Page:—
126. Application of duct endoscopy in the early diagnosis of breast cancer with nipple discharge Page:—
127. Influence of arsenic bisulfide on the expression of HSP70 in K_(562)/ADM cell Page:—
128. Effects of NOEY2 transfection on the growth of human breast cancer cell line Page:—
129. Relationship between Fas/FasL expression and apoptosis of colon adenocarcinoma cell lines Page:—
130. Committed differentiation of CD34~+ hematopoietic progenitor cells Page:—
131. Relationship between the expression of vascular endothelial growth factor and the prognosis of colon cancer patients Page:—
132. Recent advances in Eph receptors and Ephrin ligands Page:—
133. Research advances in detection of carcinoma cells in peripheral blood and its clinical significance Page:—
134. Clinical advancement of aromatase inhibitors in the therapy for human breast cancer Page:—
135. Gemcitabine and cisplatin in the treatment of advanced liver cancer Page:—
136. Combined chemotherapy for 6 patients with spinalcord implanation medulloblatoma Page:—
137. Adjuvant therapy in patients with uterine sarcomas Page:—
138. Serum nitric oxide level in the patients with oral squamous cell carcinoma and its change after operation Page:—
139. Preoperative regional chemotherapy in advanced gastric carcinoma Page:—
140. Non-operative treatment of patients with stageⅠandⅡnon-small-cell lung cancer Page:—
141. Effects of chemical splanchic denervation in reversion of T-lymphocyte subtypes level in patients suffering intractable pain with pancreatic carcinoma Page:—
142. ~(99m)Tc-tetrofosmin SPECT for the evaluation of suspicious palpable breast lesions Page:—
143. Hyperfractionated radiotherapy combined with chemotherapy for advanced esophageal carcinoma Page:—
144. Surgical treatment for 46 patients with pulmonary metastases and regressive analysis of related prognostic factors Page:—
145. Relationship between the expression of the BRCA_1 protein and clinicopathological characteristics of breast cancer Page:—
146. Expression of cyclin D1,p53 and c-myc genes and the biological behavior of gastric carcinoma Page:—
147. Significance of NF-?B expression in human cerebral tumors Page:—
148. Prediction of lymph node metastasis and the expression of cancer associated genes in endoscopic biopsy specimens of stomach cancer Page:—
149. Expression of COX-2,p53 and PCNA in esophageal carcinoma and its significance Page:—
150. Clinical significance of vascular endothelial growth factor and p53 gene expression in human gastric cancer Page:—
151. T lymphocyte activation associated membrane molecule expression in peripheral blood of patients with non-small-cell lung cancer and its clinical significance Page:—
152. Genetic polymorphisms of p53 codon72 and the risk of gastric cancer-case-control study Page:—
153. Inhibition effects of epigallocatechin-3-gallste (EGCG) on cell cycle of hum an breast cancer cells MDA-MB-435 and its mechanism Page:—